Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

TPMT*26 (208F-->L), a novel mutation detected in a Chinese.

Kham SK, Soh CK, Aw DC, Yeoh AE.

Br J Clin Pharmacol. 2009 Jul;68(1):120-3. doi: 10.1111/j.1365-2125.2009.03405.x.

2.

Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.

Vannaprasaht S, Angsuthum S, Avihingsanon Y, Sirivongs D, Pongskul C, Makarawate P, Praditpornsilpa K, Tassaneeyakul W, Tassaneeyakul W.

Clin Ther. 2009 Jul;31(7):1524-33. doi: 10.1016/j.clinthera.2009.07.008.

PMID:
19695401
3.
4.

Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.

Cao Q, Zhu Q, Shang Y, Gao M, Si J.

Digestion. 2009;79(1):58-63. doi: 10.1159/000205268. Epub 2009 Feb 28.

PMID:
19252404
5.

The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.

Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, Domański L, Droździk M.

Ther Drug Monit. 2005 Aug;27(4):435-41.

PMID:
16044099
6.
7.

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.

Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE.

Ann Intern Med. 1997 Apr 15;126(8):608-14.

PMID:
9103127
8.

The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.

Collie-Duguid ES, Pritchard SC, Powrie RH, Sludden J, Collier DA, Li T, McLeod HL.

Pharmacogenetics. 1999 Feb;9(1):37-42.

PMID:
10208641
9.

Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.

Boonsrirat U, Angsuthum S, Vannaprasaht S, Kongpunvijit J, Hirankarn N, Tassaneeyakul W, Avihingsanon Y.

Lupus. 2008 Feb;17(2):132-4. doi: 10.1177/0961203307085255.

PMID:
18250137
10.

TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.

Song DK, Zhao J, Zhang LR.

J Clin Pharm Ther. 2006 Dec;31(6):627-35.

PMID:
17176368
11.

Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.

Xin HW, Xiong H, Wu XC, Li Q, Xiong L, Yu AR.

Eur J Clin Pharmacol. 2009 Mar;65(3):249-55. doi: 10.1007/s00228-008-0589-0. Epub 2008 Dec 2.

PMID:
19048245
12.

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, Bonaz B, Soulé JC, Modigliani R, Touze Y, Catala P, Libersa C, Broly F.

Gastroenterology. 2000 Jun;118(6):1025-30.

PMID:
10833476
13.

Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?

Fangbin Z, Xiang G, Minhu C, Liang D, Feng X, Min H, Pinjin H.

Ther Drug Monit. 2012 Dec;34(6):695-701. doi: 10.1097/FTD.0b013e3182731925.

PMID:
23149442
14.

Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.

Tamori A, Shinzaki M, Kosaka S, Hayashi T, Iwai S, Enomoto M, Habu D, Sakaguchi H, Kawada N, Hino M, Shiomi S, Nishiguchi S.

Liver Int. 2007 Feb;27(1):95-100.

PMID:
17241387
15.

[Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].

Zhan ZP, Liang LQ, Yang XY, Wang YX, Huang M, Li H.

Zhonghua Yi Xue Za Zhi. 2007 Jul 3;87(25):1734-7. Chinese.

PMID:
17919375
16.

Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.

Chen D, Lian F, Yuan S, Wang Y, Zhan Z, Ye Y, Qiu Q, Xu H, Liang L, Yang X.

Clin Rheumatol. 2014 Apr;33(4):499-503. doi: 10.1007/s10067-013-2441-x. Epub 2013 Dec 10.

PMID:
24322830
17.

Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease.

Ban H, Andoh A, Tanaka A, Tsujikawa T, Sasaki M, Saito Y, Fujiyama Y.

Intern Med. 2008;47(19):1645-8. Epub 2008 Oct 1.

19.

Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.

Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA.

Pharmacogenetics. 2002 Aug;12(6):429-36.

PMID:
12172211
20.

Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases.

Cheon JH, Kim JH, Kim BY, Kim SW, Hong SY, Eun CS, Hong SS, Byeon JS, Kim TI, Han DS, Yang SK, Lee KR, Kim WH.

Hepatogastroenterology. 2009 Mar-Apr;56(90):421-3.

PMID:
19579612

Supplemental Content

Support Center